|
|
|
1-10 employees
View all
|
|
Pharmaceuticals
|
|
Medicinaregatan 8A, Gothenburg, SE
|
|
Stayble is a clinical stage pharmaceutical company developing the injection treatment STA363 for disc-related chronic low back pain. The treatment is aimed at patients whose back pain persists after physiotherapy and painkillers. The injection is given once and the effect is expected to remain throughout the entirety of the patient’s life and requires minimal rehabilitation. The Company’s focus is set upon the continued clinical development of the upcoming phase 2b study. Stayble’s vision is to develop STA363 as a new standard treatment for patients suffering from chronic disc-related low back pain.
|
Stayble Therapeutics Email Formats | Example Email Formats | Percentage |
---|---|---|
{f}{last} | [email protected] |
75.00%
|
The widely used Stayble Therapeutics email format is {f}{last} (e.g. [email protected]) with 75.00% adoption across the company.
To contact Stayble Therapeutics customer service number in your country click here to find.
Andreas Gerward is the CEO of Stayble Therapeutics. To contact Andreas Gerward email at [email protected] or [email protected]. Or you may call +46.730808397
Find accurate personal emails, work emails and phone numbers for employees
Accelerate prospecting with instant access to 300M professionals from 30M companies with the right contact details.